Clinical Trials on Alopecia in Spain

Total 18 results

Fundacion para la Investigacion Biomedica del Hospital...

Active, not recruiting

Exploratory Clinical Trial of Safety and Efficacy of Daily Application of Topical Dutasteride in Men With Androgenic Alopecia.

Male Androgenetic Alopecia

Spain
Rubina Alves
Universitat Internacional de Catalunya

Unknown

Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia (FFA)

Frontal Fibrosing Alopecia

Spain
Universitat Internacional de Catalunya

Unknown

Study to Assess Efficacy of Platelet-Rich Plasma in Androgenetic Alopecia (PRP)

Androgenetic Alopecia | Alopecia | Hair Loss

Spain
Fundació Institut de Recerca de l'Hospital de la...

Unknown

"Impact of Chemotherapy-induced Alopecia on the Quality of Life of Women With Breast Cancer"

Chemotherapy-induced Alopecia

Spain
Biotechnology Institute IMASD

Unknown

Plasma Rich in Growth Factors (PRGF-Endoret)in the Treatment of Androgenetic Alopecia

Androgenetic Alopecia

Spain
Bioithas SL
Bionou Research, S.L.

Completed

Clinical Trial to Evaluate Effectiveness of a Probiotic Preparation Administered to Patients With Alopecia Areata

Alopecia Areata

Spain
Hospital San Carlos, Madrid

Completed

Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling

Breast Cancer | Alopecia

Spain
AI Labs Group S.L
Instituto de Dermatología Integral (IDEI)

Recruiting

Clinical Workflow Optimization Using Artificial Intelligence for Dermatological Conditions (IDEI_2023)

Acne Vulgaris | Acne | Alopecia, Androgenetic | Pigmented Lesions | Pigmented Skin Lesion

Spain
Polichem S.A.

Completed

Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia

Alopecia, Androgenetic

Belgium, Germany, Hungary, Russian Federation, Spain
Bayer

Completed

A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe (Safe-CAM)

Prostate Cancer | Signs of Androgenisation in Women, e.g. Hirsutism, Androgenetic Alopecia, Acne and Seborrhea | Hypersexuality in Men | Sexual Deviations in Men

Spain, Germany, Netherlands, Poland, France
Eli Lilly and Company

Recruiting

A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata (BRAVE-AA-PEDS)

Skin Diseases | Pathological Conditions, Anatomical | Alopecia | Hypotrichosis | Hair Diseases | Areata Alopecia

United States, Japan, Taiwan, Korea, Republic of, Spain, Germany, France, Mexico, Canada, Poland, Australia, Hungary, Argentina
Applied Biology, Inc.
Hospital Universitario Ramon y Cajal

Withdrawn

In-vitro Diagnostic Test to Predict COVID-19 Mortality and Disease Severity

COVID-19 | SARS-CoV 2 | COVID | Androgenetic Alopecia | Androgen Deficiency | Androgen Receptor Abnormal

Spain
Concert Pharmaceuticals

Active, not recruiting

European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

Spain, Germany, Poland, France, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2) (THRIVE-AA2)

Alopecia Areata

Spain, United States, Poland, Canada, France, Germany, Hungary
Concert Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1) (THRIVE-AA1)

Alopecia Areata

United States, Canada, Poland, France, Spain
Pfizer

Completed

PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-2b/3)

Alopecia Areata

China, United States, Spain, Korea, Republic of, Taiwan, Canada, Australia, Germany, Czechia, Poland, Hungary, Japan, United Kingdom, Argentina, Chile, Colombia, Mexico, Russian Federation
Pfizer

Active, not recruiting

Long-Term PF-06651600 for the Treatment of Alopecia Areata (ALLEGRO-LT)

Alopecia Areata

United States, Spain, China, Korea, Republic of, Taiwan, Australia, Canada, Germany, Czechia, Poland, Japan, United Kingdom, Mexico, Argentina, Chile, Colombia, Russian Federation
Target PharmaSolutions, Inc.

Recruiting

A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC (TARGET-DERM)

Psoriasis | Atopic Dermatitis | Vitiligo | Hidradenitis Suppurativa | Alopecia Areata | Chronic Spontaneous Urticaria

United States, Spain, Canada, Germany

Clinical Trials on Alopecia in Spain

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations